Current Active Clinical Research in Japan

Clinical Research Subject (Study ID)

Site Name

Study Protocol    

Actual Funding to Date

PD001J Shonan Fujisawa Tokushukai Hospital

A Feasibility Study to Evaluate Safety and Initial Effectiveness of ExAblate Transcranial MR Guided Focused Ultrasound for Unilateral Thalamotomy in the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson’s Disease.

7,700.000

PD002J Shonan Fujisawa Tokushukai Hospital Hokuto Hospital

A Feasibility Clinical Trial of the Management of the Medically-Refractory Dyskinesia Symptoms of Advanced Idiopathic Parkinson’s Disease With Unilateral Lesioning of the Globus Pallidum Using the ExAblate Transcranial System.

3,300.000

8,800.000

PD005 Tokyo Metropolitan Neurological Hospital Shin-Yurigaoka General Hospital

Feasibility Study to Evaluate the Safety and Effectiveness of Bilateral Magnetic Resonance-guided Focused Ultrasound (MRgFUS) Ablation of the Pallido-Thalamic Tract for the Treatment of Advanced Parkinson’s Disease

1,700.000 
ET003 Osaka University Hospital
Saito Yukoukai Hospital
A Clinical Trial to Evaluate the Safety and Efficacy of Staged Bilateral ExAblate Treatment of Medication Refractory Essential Tremor   

400,000

11,600.000

ET002J        Osaka University Hospital
Saito Yukoukai Hospital

A Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects.

 
Tokyo Women’s Medical University Hospital

A Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects.

 
Hokkaido Ohno Memorial Hospital

A Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects.

 
Hokuto Hospital

A Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects.

1,000.000 
Kumagaya General Hospital

A Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects.

11,600.000

 
Shonan Fujisawa Tokushukai Hospital

A Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects.

13,900.000

 
Ohnishi Neurological Center

A Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects.

11,176.000

 
Sadamoto Hospital

A Study to Evaluate the Effectiveness and Safety of ExAblate Transcranial MRgFUS Thalamotomy Treatment of Medication Refractory Essential Tremor Subjects.

 

16,000.000

ND001   Ohnishi Neurological Center

Global Registry: ExAblate 4000 Transcranial MR Guided Focused Ultrasound of Neurological Disorders: Essential Tremor, Tremor Dominant Idiopathic Parkinson’s Disease, and Neuropathic Pain.

 
Sadamoto Hospital

Global Registry: ExAblate 4000 Transcranial MR Guided Focused Ultrasound of Neurological Disorders: Essential Tremor, Tremor Dominant Idiopathic Parkinson’s Disease, and Neuropathic Pain.

 
Nagoya Kyoritsu Hospital

Global Registry: ExAblate 4000 Transcranial MR Guided Focused Ultrasound of Neurological Disorders: Essential Tremor, Tremor Dominant Idiopathic Parkinson’s Disease, and Neuropathic Pain.

 
PMS001 Hokkaido Ohno Memorial Hospital

Post Market Survey for ExAblate 4000

 
Hokuto Hospital

Post Market Survey for ExAblate 4000

 
Kumagaya General Hospital

Post Market Survey for ExAblate 4000

 
Shonan Fujisawa Tokushukai Hospital

Post Market Survey for ExAblate 4000

 
Ohnishi Neurological Center

Post Market Survey for ExAblate 4000

 
Sadamoto Hospital

Post Market Survey for ExAblate 4000

 
Nagoya Kyoritsu Hospital

Post Market Survey for ExAblate 4000

 
Shonan Fujisawa Tokushukai Hospital

Post Market Survey for ExAblate 4000

 

以下項目にのすべてをご記入ください。 後ほど当社よりご連絡させていただきます。 (* 必須の)

agreement Error

ありがとうございます

ご記入いただき、どうもありがとうございました

ありがとうございます

This site is brought to you by INSIGHTEC, © 2018 Insightec Ltd. All rights reserved.

NGSoft logo